Bushu Pharma Applauded by Frost & Sullivan for Offering Customer Value in APAC CDMO Industry Through Consistent Quality Assurance, On-time Delivery, Sustainability, and Competitive Costs
– Frost & Sullivan researched the contract development and manufacturing organization industry and, based on its analysis, recognizes Bushu Pharmaceuticals (Pharma) with the 2024 APAC Customer Value Leadership Award. The company is a premier contract development and manufacturing organization (CDMO) of pharmaceuticals and medical devices. Renowned for its comprehensive services spanning development to distribution, the company has established itself as a market leader through a strong track record of delivering safe, high-quality products on time and cost-effectively. It leveraged deep domain knowledge, extensive experience, and Good Manufacturing Practices (GMP) certifications from major international regulatory…
Read More